Industries

Biopharma

Monoclonal antibody molecular structure

BioRaptor acts as a nexus  between research and process development in fledgling and established biopharma companies, offering a shared data structure to transition research data into process development seamlessly.

This unified framework expedites the movement from research to actionable process development strategies, ensuring swift translation of innovations into tangible process advancements. With BioRaptor, the pathway from research data to process development becomes fluid, making it an indispensable asset for biopharma entities keen on accelerating their development cycles.

Let’s get started
Monoclonal antibody molecular structure

Proven in enterprise biologics development

Biologics teams use BioRaptor to compare batches across programs, investigate deviations, and retain process knowledge over time.

A multi-asset monoclonal antibody developer

Building process knowledge across an mAb portfolio

BioRaptor connects process data, investigation history, and scientific context across multiple programs. Root-cause investigations draw on related batches and previous conclusions instead of starting again from scratch.

Multiple programs connected·200+ batches·20× faster investigations
  • Compare each batch with relevant runs across the portfolio
  • Trace deviations against prior patterns and investigations
  • Preserve conclusions and supporting data for future programs
One of the world’s largest life sciences developers and manufacturers

A step change in troubleshooting

“I’ve seen many troubleshooting efforts. With BioRaptor, it’s like entering a new world — a ChatGPT-level change in how we work.”
— Bioprocess leader

The same platform is used by production teams across advanced bioprocessing. Their products differ, but the work is familiar: align bioreactor and assay data, compare runs across scales, investigate variation, and retain what the team learned.

Transitioning from development to manufacturing is a pivotal phase, often fraught with complexities.

BioRaptor simplifies this process transfer, ensuring a seamless shift into manufacturing. By providing a consolidated platform encapsulating all necessary data and insights, the transfer of processes from development to manufacturing becomes straightforward and efficient.

This ease of transition is vital for both small and large biopharma companies aiming to maintain process integrity and product quality while speeding up the journey to manufacturing.

BioRaptor’s prowess extends to integrating whole process data

BioRaptor’s prowess extends to integrating whole process data with individual process step Design of Experiments (DOEs), furnishing an end-to-end process control strategy. Our commitment to speeding up your time to market is evident through features like cross-experiment analysis, robust visualization tools, and collaborative functionalities—each tailored to meet the unique demands of the biopharma industry.

The platform enables the construction of an in-process signature database across all stages of development and manufacturing to bolster comparability.

The generation and utilization of in-process signatures enhance real-time monitoring and control, while the database becomes instrumental for comparative analysis across different stages of development and manufacturing.

This rich and structured repository of in-process insights and historical data comparison is pivotal for continuous improvement and ensuring regulatory compliance, making BioRaptor a comprehensive and forward-thinking solution for the dynamic biopharma landscape.

Get in touch